Am. J. Respir. Cell Mol. Biol., Volume 18, Number 6, June, 1998 860-866

CD44 and CD69 Represent Different Types of Cell-surface Activation Markers for Human Eosinophils

Kenji Matsumoto, James Appiah-Pippim, Robert P. Schleimer, Carol A. Bickel, Lisa A. Beck, and Bruce S. Bochner

Department of Medicine, Johns Hopkins University School of Medicine at the Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland

Eosinophils (EOS) purified from peripheral blood or late-phase bronchoalveolar lavage (BAL) were analyzed with 473 monoclonal antibodies (mAbs) from the Fifth International Workshop on Human Leukocyte Antigens in an attempt to identify markers of EOS activation. Two strategies were used: (1) to look for surface markers absent on fresh EOS but present after in vivo activation (e.g., in late-phase BAL fluid [BALF]) or after in vitro culture for up to 72 h with cytokines ( 10 ng/ml of interleukin-3 [IL-3], IL-5, or granulocyte-macrophage colony-stimulating factor [GM-CSF]); and (2) to look for markers constitutively expressed on fresh EOS that were increased after activation in vivo or after culture in vitro. With indirect immunofluorescence and flow cytometry, the first approach revealed that among approximately 350 mAbs tested, only those recognizing CD69 became bound to late-phase BALF EOS or cytokine-cultured EOS, but not to fresh EOS. Using the second approach, we observed statistically significant concentration- and time-dependent increases in CD44 expression in EOS cultured with IL-3, IL-5, or GM-CSF (~ 2-fold increase in fluorescence intensity, P < 0.05), but not with interferon- (IFN-) (up to 100 ng/ml), whereas levels of 15 other constitutively expressed markers were unchanged. Despite increased expression, neither fresh nor cytokine-cultured EOS adhered to immobilized hyaluronate, a ligand for CD44. Additionally, simultaneous comparison of hypodense (specific gravity < 1.085 g/liter) and normodense (specific gravity > 1.085 g/liter) EOS from allergic donors consistently revealed higher levels of CD44 expression (~ 3- to 8-fold) but not CD69 expression on hypodense EOS. We conclude that CD69 and CD44 represent different types of activation markers for human EOS. These findings may be useful in assessing the state of EOS activation in vitro and in vivo.

This article has been cited by other articles:

				J. H. Kang, D. H. Lee, H. Seo, J. S. Park, K. H. Nam, S. Y. Shin, C.-S. Park, and I. Y. Chung Regulation of Functional Phenotypes of Cord Blood Derived Eosinophils by {gamma}-Secretase Inhibitor Am. J. Respir. Cell Mol. Biol., November 1, 2007; 37(5): 571 - 577. [Abstract] [Full Text] [PDF]

				H. Abdala-Valencia, J. Earwood, S. Bansal, M. Jansen, G. Babcock, B. Garvy, M. Wills-Karp, and J. M. Cook-Mills Nonhematopoietic NADPH oxidase regulation of lung eosinophilia and airway hyperresponsiveness in experimentally induced asthma Am J Physiol Lung Cell Mol Physiol, May 1, 2007; 292(5): L1111 - L1125. [Abstract] [Full Text] [PDF]

				A. Munitz, I. Bachelet, R. Eliashar, A. Moretta, L. Moretta, and F. Levi-Schaffer The inhibitory receptor IRp60 (CD300a) suppresses the effects of IL-5, GM-CSF, and eotaxin on human peripheral blood eosinophils Blood, March 1, 2006; 107(5): 1996 - 2003. [Abstract] [Full Text] [PDF]

				M Lampinen, A Ronnblom, K Amin, G Kristjansson, F Rorsman, P Sangfelt, B Safsten, M Wagner, A Wanders, O Winqvist, et al. Eosinophil granulocytes are activated during the remission phase of ulcerative colitis Gut, December 1, 2005; 54(12): 1714 - 1720. [Abstract] [Full Text] [PDF]

				T. Homma, A. Kato, N. Hashimoto, J. Batchelor, M. Yoshikawa, S. Imai, H. Wakiguchi, H. Saito, and K. Matsumoto Corticosteroid and Cytokines Synergistically Enhance Toll-Like Receptor 2 Expression in Respiratory Epithelial Cells Am. J. Respir. Cell Mol. Biol., October 1, 2004; 31(4): 463 - 469. [Abstract] [Full Text] [PDF]

				A. D. Klion, M. A. Law, W. Riemenschneider, M. L. McMaster, M. R. Brown, M. Horne, B. Karp, M. Robinson, V. Sachdev, E. Tucker, et al. Familial eosinophilia: a benign disorder? Blood, June 1, 2004; 103(11): 4050 - 4055. [Abstract] [Full Text] [PDF]

				M. E. Bates, L. Y. Liu, S. Esnault, B. A. Stout, E. Fonkem, V. Kung, J. B. Sedgwick, E. A. B. Kelly, D. M. Bates, J. S. Malter, et al. Expression of Interleukin-5- and Granulocyte Macrophage-Colony-Stimulating Factor-Responsive Genes in Blood and Airway Eosinophils Am. J. Respir. Cell Mol. Biol., May 1, 2004; 30(5): 736 - 743. [Abstract] [Full Text] [PDF]

				S. Esnault and J. S. Malter Hyaluronic Acid or TNF-{alpha} Plus Fibronectin Triggers Granulocyte Macrophage-Colony-Stimulating Factor mRNA Stabilization in Eosinophils Yet Engages Differential Intracellular Pathways and mRNA Binding Proteins J. Immunol., December 15, 2003; 171(12): 6780 - 6787. [Abstract] [Full Text] [PDF]

				M-J. Dallaire, C. Ferland, N. Page, S. Lavigne, F. Davoine, and M. Laviolette Endothelial cells modulate eosinophil surface markers and mediator release Eur. Respir. J., June 1, 2003; 21(6): 918 - 924. [Abstract] [Full Text] [PDF]

				E. Mattsson, T. Persson, P. Andersson, J. Rollof, and A. Egesten Peptidoglycan Induces Mobilization of the Surface Marker for Activation Marker CD66b in Human Neutrophils but Not in Eosinophils Clin. Vaccine Immunol., May 1, 2003; 10(3): 485 - 488. [Abstract] [Full Text] [PDF]

				M. Triggiani, F. Granata, B. Balestrieri, A. Petraroli, G. Scalia, L. Del Vecchio, and G. Marone Secretory Phospholipases A2 Activate Selective Functions in Human Eosinophils J. Immunol., March 15, 2003; 170(6): 3279 - 3288. [Abstract] [Full Text] [PDF]

				K. Y. Larbi, A. R. Allen, F. W. K. Tam, D. O. Haskard, R. R. Lobb, P. M. R. Silva, and S. Nourshargh VCAM-1 has a tissue-specific role in mediating interleukin-4-induced eosinophil accumulation in rat models: evidence for a dissociation between endothelial-cell VCAM-1 expression and a functional role in eosinophil migration Blood, November 15, 2000; 96(10): 3601 - 3609. [Abstract] [Full Text] [PDF]

				Y. Ohkawara, G. Tamura, T. Iwasaki, A. Tanaka, T. Kikuchi, and K. Shirato Activation and Transforming Growth Factor-beta Production in Eosinophils by Hyaluronan Am. J. Respir. Cell Mol. Biol., October 1, 2000; 23(4): 444 - 451. [Abstract] [Full Text]

				M.-C. Seminario, S. S. Saini, D. W. MacGlashan Jr., and B. S. Bochner Intracellular Expression and Release of Fc{epsilon}RI{alpha} by Human Eosinophils J. Immunol., June 1, 1999; 162(11): 6893 - 6900. [Abstract] [Full Text] [PDF]

				H. Kita, M. Kaneko, K. R. Bartemes, D. A. Weiler, A. W. Schimming, C. E. Reed, and G. J. Gleich Does IgE Bind to and Activate Eosinophils from Patients with Allergy? J. Immunol., June 1, 1999; 162(11): 6901 - 6911. [Abstract] [Full Text] [PDF]

				M. H. Grayson, M. Van der Vieren, S. A. Sterbinsky, W. Michael Gallatin, P. A. Hoffman, D. E. Staunton, and B. S. Bochner alpha dbeta 2 Integrin Is Expressed on Human Eosinophils and Functions as an Alternative Ligand for Vascular Cell Adhesion Molecule 1 (VCAM-1) J. Exp. Med., December 7, 1998; 188(11): 2187 - 2191. [Abstract] [Full Text] [PDF]